Location of Repository

CLEC-2 activates Syk through dimerization

By C. E. Hughes, A. Y. Pollitt, J. Mori, J. A. Eble, Michael G. Tomlinson, J. H. Hartwig, C. A. O'Callaghan, K. Futterer and Steve P Watson

Abstract

The C-type lectin receptor CLEC-2 activates platelets through Src and Syk tyrosine kinases, leading to tyrosine phosphorylation of downstream adapter proteins and effector enzymes, including phospholipase-C 2. Signaling is initiated through phosphorylation of a single conserved tyrosine located in a YxxL sequence in the CLEC-2 cytosolic tail. The signaling pathway used by CLEC-2 shares many similarities with that used by receptors that have 1 or more copies of an immunoreceptor tyrosine-based activation motif, defined by the sequence Yxx(L/I)x6-12Yxx(L/I), in their cytosolic tails or associated receptor chains. Phosphorylation of the conserved immunoreceptor tyrosine-based activation motif tyrosines promotes Syk binding and activation through binding of the Syk tandem SH2 domains. In this report, we present evidence using peptide pull-down studies, surface plasmon resonance, quantitative Western blotting, tryptophan fluorescence measurements, and competition experiments that Syk activation by CLEC-2 is mediated by the cross-linking through the tandem SH2 domains with a stoichiometry of 2:1. In support of this model, cross-linking and electron microscopy demonstrate that CLEC-2 is present as a dimer in resting platelets and converted to larger complexes on activation. This is a unique mode of activation of Syk by a single YxxL-containing recepto

Topics: R Medicine (General)
Year: 2010
DOI identifier: 10.1182/blood-2009-08-237834
OAI identifier: oai:eprints.bham.ac.uk:338

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.